Revenue in the second quarter was $1.9m (€1.5m), a year-on-year increase of three per cent. However, this is still down on the performance in the second quarter of 2008, when Datatrak generated revenue of $2.2m.
Sales growth in the second quarter helped Datatrak record an operating profit of $27,290. In the corresponding period of 2009 Datatrak posted an operating loss of $36,181, primarily as a result of severance expenses.
Datatrak also continued to grow its backlog. As of June 30 backlog was $10.9m, up year-on-year by 27 per cent. However, this is again lower than historic levels, such as the $13.2m backlog Datatrak had on June 30 2008.
Despite this, Laurence Birch, chairman of the Datatrak board, was bullish about the company’s prospects. He said: “The word is getting out that Datatrak is back in the game, as evidenced by the significant increase in traffic through our booth at the recent DIA meeting.”
At DIA Datatrak generated 500 qualified leads, said Birch, and it also exhibited at the 2010 ASCO annual meeting and presented at the 2010 OneMedForum as part of continued marketing efforts.
In the second quarter Datatrak expanded its strategic partnership in Japan with NTT Data. The revised partnership allows NTT to sell enterprise transfer services in Japan and has entered into its first agreement in this area, generating additional revenues for both partners.
Datatrak has also inked a deal with its first Portuguese client, Keypoint Scientific Consultancy, and been selected by Daiichi Sankyo for a cardiovascular trial in Europe. Daiichi will use Datatrak’s eClinical platform for the trial, which spans 80 sites and 1,200 patients.